Congress and Ozempic Funding Controversy

Today, over a hundred members of Congress

support a bill to fund Ozempic with Medicare

at $1,500 a month.

Most of these members have taken money

from the manufacturer of that product,

a European company called Novo Nordisk.

As everyone knows,

once a drug is approved for Medicare,

it goes to Medicaid.

And there is a push to recommend Ozempic

for Americans as young as six

over a condition of obesity

that is completely preventable and barely even existed 100 years ago.

Since 74% of Americans are obese,

the cost of all of them,

if they take their Ozempic prescriptions,

will be $3 trillion a year.

This is a drug that has made Novo Nordisk

the biggest company in Europe.

It's a Danish company,

but the Danish government does not recommend it.

It recommends a change in diet to treat obesity

and exercise.

Virtually Novo Nordisk's entire value is based upon

its projections of what Ozempic is going to sell to Americans.

For half the price of Ozempic,

we could purchase regeneratively raised organic agriculture

and organic food for every American,

three meals a day,

and gym membership for every obese American.

Why are members of Congress doing the bidding

of this Danish company

instead of standing up for American farmers and

children?

Because Novo Nordisk is one of the largest funders of medical research,

the media and politicians and

the medical schools all go along with them.